XML 39 R26.htm IDEA: XBRL DOCUMENT v3.7.0.1
Fair Value Measurements (Tables)
12 Months Ended
Mar. 31, 2017
Fair Value Disclosures [Abstract]  
Fair value of assets and liabilities on a recurring basis
The following tables set forth by level within the fair value hierarchy our financial assets and liabilities that were accounted for at fair value on a recurring basis at March 31, 2017 and March 31, 2016:
 
Balance at
 
Quoted Prices in Active Markets for Identical Assets (Level 1)
 
Significant Other Observable Inputs (Level 2)
 
Unobservable Inputs (Level 3)
 
March 31,
2017
 
 
 
ASSETS
 
 
 
 
 
 
 
Cash and cash equivalents (1)
$
37,673

 
$
37,673

 
$

 
$

Restricted cash and cash equivalents
4,916

 
4,916

 

 

 
$
42,589

 
$
42,589

 
$

 
$

LIABILITIES
 
 
 
 
 
 
 
Contingent consideration related to acquisitions
$
18,817

 
$

 
$
18,817

 
$

 
$
18,817

 
$

 
$
18,817

 
$

 
Balance at
 
Quoted Prices in Active Markets for Identical Assets (Level 1)
 
Significant Other Observable Inputs (Level 2)
 
Unobservable Inputs (Level 3)
 
March 31,
2016
 
 
 
ASSETS
 
 
 
 
 
 
 
Cash and cash equivalents (1)
$
27,176

 
$
27,176

 
$

 
$

Restricted cash and cash equivalents
5,320

 
5,320

 

 

Marketable securities (2)
9,297

 
9,297

 

 

 
$
41,793

 
$
41,793

 
$

 
$

LIABILITIES
 
 
 
 
 
 
 
Contingent consideration related to acquisitions
$
23,843

 
$

 
$

 
$
23,843

 
$
23,843

 
$

 
$

 
$
23,843

___________________________________
(1) Cash equivalents consist primarily of money market funds.
(2) Marketable securities consist of available-for-sale money market instruments and fixed-income securities, including certificates of deposit, corporate bonds and notes, and municipal securities.
Company's assets and liabilities measured at fair value using significant unobservable inputs (Level 3)
The following table presents activity in our financial assets and liabilities measured at fair value using significant unobservable inputs (Level 3), as of and for the years ended March 31, 2017:
 
 
Total Liabilities
Balance at March 31, 2015
 
$
16,155

Contingent consideration related to acquisition of HealthFusion (Note 5)
 
16,700

Settlement of share-based contingent consideration related to Mirth
 
(9,273
)
Fair value adjustments, net
 
261

Balance at March 31, 2016
 
$
23,843

Settlement of share-based contingent consideration related to Mirth
 
(9,273
)
Fair value adjustments, net
 
4,247

Transfer of HealthFusion contingent consideration to Level 2
 
(18,817
)
Balance at March 31, 2017
 
$